Russell Investments Group, Ltd. Xenon Pharmaceuticals Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 223,614 shares of XENE stock, worth $8.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

223,614

Previous 162,850 37.31%

Holding current value

$8.7 Million

Previous $6.35 Million 38.59%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$36.12 - $43.96 $2.19 Million - $2.67 Million	60,764 Added 37.31%	223,614 $8.8 Million
Q2 2024 Aug 08, 2024	SELL	$36.25 - $43.75 $552,776 - $667,143	-15,249 Reduced 8.56%	162,850 $6.35 Million
Q1 2024 May 08, 2024	BUY	$42.66 - $50.04 $162,662 - $190,802	3,813 Added 2.19%	178,099 $7.67 Million
Q4 2023 Feb 05, 2024	BUY	$28.7 - $46.46 $140,572 - $227,561	4,898 Added 2.89%	174,286 $8.03 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $646,717 - $752,168	18,932 Added 12.58%	169,388 $5.79 Million
Q2 2023 Aug 10, 2023	BUY	$34.84 - $43.54 $2.27 Million - $2.83 Million	65,098 Added 76.26%	150,456 $5.79 Million
Q1 2023 May 09, 2023	BUY	$33.46 - $40.35 $34,396 - $41,479	1,028 Added 1.22%	85,358 $3.05 Million
Q4 2022 Feb 08, 2023	SELL	$33.06 - $39.43 $487,436 - $581,355	-14,744 Reduced 14.88%	84,330 $3.33 Million
Q3 2022 Nov 04, 2022	SELL	$30.79 - $39.82 $271,721 - $351,411	-8,825 Reduced 8.18%	99,074 $3.58 Million
Q2 2022 Jul 29, 2022	BUY	$25.44 - $35.16 $864,451 - $1.19 Million	33,980 Added 45.97%	107,899 $3.28 Million
Q1 2022 May 05, 2022	BUY	$25.09 - $33.13 $545,657 - $720,511	21,748 Added 41.69%	73,919 $2.26 Million
Q4 2021 Jan 21, 2022	BUY	$15.6 - $35.4 $432,291 - $980,969	27,711 Added 113.29%	52,171 $1.63 Million
Q4 2019 Jan 29, 2020	SELL	$8.11 - $14.65 $101,731 - $183,769	-12,544 Reduced 33.9%	24,460 $320,000
Q3 2019 Nov 01, 2019	SELL	$8.74 - $10.51 $404,452 - $486,360	-46,276 Reduced 55.57%	37,004 $332,000
Q2 2019 Aug 09, 2019	BUY	$8.51 - $10.75 $669,558 - $845,799	78,679 Added 1710.04%	83,280 $821,000
Q1 2019 May 13, 2019	BUY	$6.39 - $10.42 $2,485 - $4,053	389 Added 9.24%	4,601 $47,000
Q4 2018 Feb 11, 2019	BUY	$5.61 - $12.62 $23,629 - $53,155	4,212 New	4,212 $27,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Xenon Pharmaceuticals Inc. Transaction History